These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4080525)

  • 1. [Estimation of the mean cost of collective dose per capita in various countries of the world].
    Hashizume T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Jul; 45(7):1059-61. PubMed ID: 4080525
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose response of radiation induced cancer.
    Kato H
    J UOEH; 1983 Mar; 5 Suppl():169-73. PubMed ID: 6679667
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medical irradiation in Japan - stochastic risk estimation and its reduction (author's transl)].
    Hashizume T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 May; 41(5):445-74. PubMed ID: 7301534
    [No Abstract]   [Full Text] [Related]  

  • 4. [Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. 2. Estimation of genetically significant dose, per caput mean bone marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Yamaguchi H; Nishizawa K; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Jul; 39(7):747-60. PubMed ID: 492934
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimation of life shortening resulting from radiogenic cancer per rem of absorbed dose.
    Gotchy RL
    Health Phys; 1978 Oct; 35(4):563-5. PubMed ID: 748261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the risk due to medical irradiation].
    Hashizume T
    Rinsho Hoshasen; 1981 Feb; 26(2):335-8. PubMed ID: 7289130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effective per capita dosage as a measure for medically determined radiation exposure of the population--a supplement or alternative to the genetically significant dosage?].
    Kaul A; Hinz G; Kossel F; König K; Kragh P; Nitschke J; Roedler HD; Schwarz ER
    Strahlenschutz Forsch Prax; 1985; 26():168-82. PubMed ID: 4089901
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estimation of stochastic risk from computed tomographic examinations in Japan, 1979. 3. Estimation of population doses and stochastic risks (author's transl)].
    Nishizawa K; Maruyama T; Iwata T; Furuya Y; Hashizume T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 May; 41(5):436-41. PubMed ID: 7301533
    [No Abstract]   [Full Text] [Related]  

  • 9. [Population doses from beam-therapy in Japan, 1978. Part 3. Estimation of malignancy significant dose and fatal malignant risk (author's transl)].
    Hashizume T; Matsuzawa H; Maruyama T; Kawachi K; Noda Y; Shiragai A; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Feb; 41(2):158-67. PubMed ID: 7267299
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis.
    Kai M; Luebeck EG; Moolgavkar SH
    Radiat Res; 1997 Oct; 148(4):348-58. PubMed ID: 9339951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age- and sex-specific analysis of homicide mortality as a function of economic development: a cross-national comparison.
    Moniruzzaman S; Andersson R
    Scand J Public Health; 2005; 33(6):464-71. PubMed ID: 16332611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stochastic risk estimation from medical x-ray diagnostic examinations (author's transl)].
    Hashizume T; Maruyama T; Noda Y; Fukuhisa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 Sep; 40(9):885-97. PubMed ID: 7454536
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing the risk of exposure to radioactivity.
    Crawford DJ; Leggett RW
    Am Sci; 1980; 68(5):524-36. PubMed ID: 7425427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Estimation of frequency, population doses and stochastic risks in medical uses of radiopharmaceuticals in Japan, 1982. 1. The number of medical examinations using radiopharmaceuticals].
    Maruyama T; Noda Y; Kumamoto Y; Nishizawa K; Iwai K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Jul; 48(7):911-20. PubMed ID: 3194183
    [No Abstract]   [Full Text] [Related]  

  • 15. [Radiation and leukemia (author's transl)].
    Ichimaru M
    Radioisotopes; 1980 Dec; 29(12):622-31. PubMed ID: 7244311
    [No Abstract]   [Full Text] [Related]  

  • 16. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 2. Estimation of genetically significant dose (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Mar; 36(3):208-15. PubMed ID: 1066647
    [No Abstract]   [Full Text] [Related]  

  • 17. [The 10 main causes of death].
    Assist Inferm Ric; 2007; 26(1):51-4. PubMed ID: 17489340
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catastrophic illness expense: implications for national health policy in the United States.
    Schwartz M; Naierman N; Birnbaum H
    Soc Sci Med (1967); 1978 Jun; 12(1C-2C):13-22. PubMed ID: 100885
    [No Abstract]   [Full Text] [Related]  

  • 20. Time trends of primary liver cancer: indication of increased incidence in selected cancer registry populations.
    Saracci R; Repetto F
    J Natl Cancer Inst; 1980 Aug; 65(2):241-7. PubMed ID: 6931246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.